Susquehanna Fundamental Investments LLC Acquires Shares of 9,070 Globe Life Inc. $GL

Susquehanna Fundamental Investments LLC bought a new stake in shares of Globe Life Inc. (NYSE:GL) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 9,070 shares of the company’s stock, valued at approximately $1,621,000.

Several other large investors also recently modified their holdings of GL. BlackRock Inc. bought a new stake in Globe Life during the second quarter worth about $987,901,000. Pzena Investment Management LLC bought a new position in Globe Life in the 2nd quarter valued at about $242,256,000. Norges Bank acquired a new position in shares of Globe Life in the 4th quarter valued at approximately $155,617,000. Northwestern Mutual Wealth Management Co. lifted its holdings in shares of Globe Life by 34,786.0% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 881,919 shares of the company’s stock worth $123,345,000 after acquiring an additional 879,391 shares during the period. Finally, AQR Capital Management LLC lifted its holdings in shares of Globe Life by 98.6% during the 2nd quarter. AQR Capital Management LLC now owns 1,402,690 shares of the company’s stock worth $174,340,000 after acquiring an additional 696,548 shares during the period. 81.61% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts have commented on the stock. Weiss Ratings downgraded shares of Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research report on Monday, July 20th. Keefe, Bruyette & Woods decreased their price target on Globe Life from $192.00 to $190.00 and set an “outperform” rating on the stock in a research note on Friday, July 24th. JPMorgan Chase & Co. boosted their price target on Globe Life from $181.00 to $201.00 and gave the stock an “overweight” rating in a report on Tuesday, July 21st. Morgan Stanley upped their price objective on Globe Life from $181.00 to $208.00 and gave the stock an “overweight” rating in a research report on Monday, July 6th. Finally, Wells Fargo & Company raised their price objective on Globe Life from $172.00 to $193.00 and gave the company an “overweight” rating in a research note on Thursday, July 9th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, Globe Life has an average rating of “Moderate Buy” and a consensus price target of $191.67.

Globe Life Stock Performance

Shares of Globe Life stock opened at $172.13 on Wednesday. Globe Life Inc. has a fifty-two week low of $127.85 and a fifty-two week high of $191.55. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.07 and a quick ratio of 0.07. The firm has a market capitalization of $13.23 billion, a P/E ratio of 11.43 and a beta of 0.47. The company’s 50 day moving average price is $178.71 and its two-hundred day moving average price is $160.07.

Globe Life (NYSE:GL) last announced its quarterly earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.67 by ($0.06). Globe Life had a return on equity of 20.52% and a net margin of 19.58%.The company had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same quarter last year, the company posted $3.05 earnings per share. The firm’s quarterly revenue was up 8.0% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. On average, equities analysts forecast that Globe Life Inc. will post 15.71 earnings per share for the current fiscal year.

Globe Life Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Monday, October 5th will be issued a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Monday, October 5th. Globe Life’s dividend payout ratio is presently 8.76%.

Globe Life declared that its Board of Directors has approved a share repurchase program on Monday, August 10th that allows the company to buyback $2.50 billion in outstanding shares. This buyback authorization allows the company to reacquire up to 17.7% of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s board believes its shares are undervalued.

Insiders Place Their Bets

In other news, CEO Frank M. Svoboda sold 10,000 shares of the business’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $166.68, for a total transaction of $1,666,800.00. Following the sale, the chief executive officer directly owned 54,020 shares in the company, valued at approximately $9,004,053.60. The trade was a 15.62% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO James Matthew Darden sold 50,000 shares of the company’s stock in a transaction that occurred on Friday, July 31st. The shares were sold at an average price of $182.43, for a total value of $9,121,500.00. Following the completion of the transaction, the chief executive officer directly owned 58,451 shares of the company’s stock, valued at $10,663,215.93. This represents a 46.10% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 151,908 shares of company stock worth $27,239,981. Company insiders own 2.11% of the company’s stock.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.